PARPis As Immune Modulating Agents in Preventing Ovarian Cancer Recurrence

Authors

• Melayshia McFadden, Morehouse School of MedicineFollow
• Natalie Ngoi, The University of Texas MD Anderson Cancer Center
• Xueqian Cheng, The University of Texas MD Anderson Cancer CenterFollow
• Guang Peng, The University of Texas MD Anderson Cancer CenterFollow

Files

Keywords

Ovarian Cancer; Parp Inhibitors; BRCA; Recurrence; Immune Response

Program Affiliation

CPRTP Summer Research Experience

Recommended Citation

McFadden, Melayshia; Ngoi, Natalie; Cheng, Xueqian; and Peng, Guang, "PARPis As Immune Modulating Agents in Preventing Ovarian Cancer Recurrence" (2022). Summer Experience 2022. 142.
https://openworks.mdanderson.org/sumexp22/142